神奈木玲兒博士
退休研究員
Specialty:
- Cancer-associated Glycans
- Lymphocyte Homing
- Selectins, Siglecs and CD44
Education and Positions:
M.D., Ph.D. Kyoto University
Dr. Kannagi, Reiji 's
Research Highlights
BGN/TLR4/NF-B Mediates Epigenetic Silencing of Immunosuppressive Siglec Ligands in Colon Cancer Cells
Cells, Feb 09, 2020
SSEA3 and Sialyl Lewis a Glycan Expression Is Controlled by B3GALT5 LTR through Lamin A-NFYA and SIRT1-STAT3 Signaling in Human ES Cells
Cells, Jan 10, 2020
Epigenetic silencing of the synthesis of immunosuppressive Siglec ligand glycans by NF-κB/EZH2/YY1 axis in early-stage colon cancers
Biochimica et Biophysica Acta-Gene Regulatory Mechanisms, Feb 01, 2019